https://www.indianpharmapost.com/indegene-posts-q1-net-profit-higher-by-33-yoy-to-rs-1164-cr-175422025-08-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/vertex-faces-regulatory-delays-for-journavx-and-reports-vx-993-phase-2-trial-failure-175522025-08-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/novo-nordisk-files-14-new-lawsuits-against-unapproved-semaglutide-drugs-175512025-08-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/roches-susvimo-maintains-vision-over-five-years-175502025-08-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/cadila-pharmaceuticals-launches-vasograin-plus-for-treatment-of-migraines-175482025-08-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/abbvie-announces-positive-phase-3-results-for-upadacitinib-in-alopecia-areata-175472025-08-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/athena-diagnostics-enhances-ataxia-testing-with-long-read-gene-sequencing-175462025-08-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/abbvie-submits-for-fda-approval-of-venclexta-and-acalabrutinib-combination-for-untreated-cll-patients-175452025-08-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/gland-pharma-q1-fy26-yoy-pat-up-by-50-to-rs-216-cr-175442025-08-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/alembic-pharmaceuticals-q1-fy26-revenue-up-10-net-profit-up-15-175432025-08-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/revvity-launches-reagent-technology-for-targeted-therapeutics-175532025-08-06T00:00:00+05:30always0.9